A detailed history of Hrt Financial LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 64,053 shares of RVMD stock, worth $2.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
64,053
Holding current value
$2.39 Million
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$26.56 - $33.55 $1.7 Million - $2.15 Million
64,053 New
64,053 $2.06 Million
Q4 2022

Feb 10, 2023

BUY
$17.68 - $25.53 $1.74 Million - $2.51 Million
98,186 New
98,186 $2.34 Million
Q2 2022

Aug 12, 2022

BUY
$14.54 - $27.17 $422,561 - $789,614
29,062 Added 44.45%
94,448 $1.84 Million
Q1 2022

May 16, 2022

BUY
$17.31 - $26.4 $643,135 - $980,865
37,154 Added 131.6%
65,386 $1.67 Million
Q4 2021

Feb 14, 2022

BUY
$24.35 - $33.7 $687,449 - $951,418
28,232 New
28,232 $710,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.28B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.